University of Glasgow,
(United Kingdom of Great Britain & Northern Ireland)
Risk Factors and Prevention
Follow me on:
Professor Naveed Sattar is one of the world’s top diabetes/metabolic medicine experts. Based in the Institute of Cardiovascular & Medical Sciences at the University of Glasgow, he is a Clarivate Analytics Global Highly Cited Researcher for 2019, one of ten Glasgow researchers recognised as being in the top 1% for citations in their academic field.
His research focuses on the prevention and management of diabetes, obesity and CVD. He has published over 950 papers, participated in multiple guidelines and clinical trials, as well as been the recipient of multiple award lectures.
His main contributions have helped define CVD risks in diabetes including the relevance of age of onset, ethnicity, specific drugs, and sex. He has also helped define CVD risks in autoimmune conditions and has helped improve knowledge on general CVD risk factors including lipids, role of obesity, and alcohol. He also has a track record of work on novel biomarkers. He is involved in several ongoing trials.
ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.
Our mission: To reduce the burden of cardiovascular disease